Science Explorer Interactive view Map
Company · Tokyo · Japan

EA Pharma (Japan)

eapharma.co.jpROR OpenAlex
Research works
64
▲ 58% vs 2013–17
Citations
1.1k
16.8 per fractional work
Top-10% rate
18.5%
record average 16.5%
Open access
71%
world 28%

Not ranked overall: EA Pharma (Japan) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.14× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.48× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 2.98× its world share, 1 worksImmunology and Micro…Neuroscience: 0.67× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 5.72× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.72× its world share, 1 worksChemistryComputer Science: 0.02× its world share, 0 worksComputer ScienceHealth Professions: 0.60× its world share, 0 worksHealth ProfessionsMedicine: 3.80× its world share, 18 worksMedicineVeterinary: 0.85× its world share, 0 worksVeterinaryArts and Humanities: 0.68× its world share, 0 worksArts and HumanitiesPsychology: 0.14× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 5.7×. Every wedge is a field page.

Which keywords describe research at EA Pharma (Japan)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Inflammation, Epidemiology, JAK2 Mutation, Myelofibrosis, Cancer, Pathogenesis, Microbiota and Intestinal Permeability.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 18 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 18 words, with their numbers
  1. Inflammation5▲ 8.8×17 topics
  2. Epidemiology4▲ 3.8×17 topics
  3. JAK2 Mutation3▲ 426×1 topic
  4. Myelofibrosis3▲ 426×1 topic
  5. Cancer2▲ 5.8×8 topics
  6. Pathogenesis2▲ 11×5 topics
  7. Inflammatory Bowel Disease1▲ 47×2 topics
  8. Intestinal Permeability1▲ 113×2 topics
  9. Microbiota1▲ 26×2 topics
  10. Classification1▲ 11×3 topics
  11. Enteric Nervous System1▲ 120×2 topics
  12. Proton Pump Inhibitors1▲ 77×2 topics
  13. Gastrointestinal Disorders1▲ 84×1 topic
  14. Genetics1▲ 6.7×3 topics
  15. Irritable Bowel Syndrome1▲ 149×1 topic
  16. Fusion Genes1▲ 183×1 topic
  17. Hypereosinophilic Syndrome1▲ 183×1 topic
  18. Prognostic Factors1▲ 9.8×4 topics

Which research topics does EA Pharma (Japan) publish most on?

By volume in 2022–2025: Myeloproliferative Neoplasms: Diagnosis and Treatment, Gastrointestinal motility and disorders, Eosinophilic Disorders and Syndromes and Inflammatory Bowel Disease.

Myeloproliferative Neopl…3Myeloproliferative Neoplasms: Diagnosis and Treatment: 3 fractional worksGastrointestinal motilit…1Gastrointestinal motility and disorders: 1 fractional worksEosinophilic Disorders a…1Eosinophilic Disorders and Syndromes: 1 fractional worksInflammatory Bowel Disease: 1 fractional worksAcute Myeloid Leukemia Research: 1 fractional worksGastroesophageal reflux …1Gastroesophageal reflux and treatments: 1 fractional worksPlatelet Disorders and Treatments: 1 fractional worksChronic Myeloid Leukemia Treatments: 1 fractional worksCell Adhesion Molecules Research: 0 fractional worksPharmaceutical studies and practices: 0 fractional works
GeneticsGastroenterologyRheumatologyHematology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 3 works
  2. 2 Gastrointestinal motility and disorders Gastroenterology 1 works
  3. 3 Eosinophilic Disorders and Syndromes Rheumatology 1 works
  4. 4 Inflammatory Bowel Disease Genetics 1 works
  5. 5 Acute Myeloid Leukemia Research Hematology 1 works
  6. 6 Gastroesophageal reflux and treatments Gastroenterology 1 works
  7. 7 Platelet Disorders and Treatments Hematology 1 works
  8. 8 Chronic Myeloid Leukemia Treatments Hematology 1 works
  9. 9 Cell Adhesion Molecules Research Immunology and Allergy 0 works
  10. 10 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available70.8%not open29.2%

World: 28% of research is openly available.

with international co-authors22.2%domestic only77.8%

World: 19% is written across borders.

How has EA Pharma (Japan)'s research output changed?

Output in 2018–2022 was 58% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Tokyo

All research institutions in Tokyo

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.